Abbott Laboratories vs. Tonix Pharmaceuticals Holding Corp.
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | TNXP | |
|---|---|---|
| Market Cap | $168.71 billion | $138.41 million |
| Revenue (TTM) | — | $29.10 million |
| Net Income (TTM) | — | $-159,666,000 |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | TNXP | |
|---|---|---|
| Price / Book | — | 0.62 |
| Price / Sales | — | 4.76 |
ABT and TNXP split the valuation factors evenly.
Profitability
| ABT | TNXP | |
|---|---|---|
| Net Margin | — | -548.64% |
| Return on Equity | — | -71.83% |
ABT and TNXP split the profitability factors evenly.
Dividend
| ABT | TNXP | |
|---|---|---|
| Dividend Yield | 2.58% | — |
ABT and TNXP split the dividend factors evenly.
Risk & Sentiment
| ABT | TNXP | |
|---|---|---|
| Short Interest | 0.57% | 1.64% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, TNXP overview, TNXP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.